Memphis, Tenn.-based Medtronic Spine has announced intentions to restructure its workforce, including possible employee layoffs and other cost-cutting measures, according to a company statement.
Spinal Tech
Medtronic has begun enrolling patients in its clinical trial for a back pain treatment device, according to the Memphis Business Journal.
Device costs are a huge portion of surgical bills, and 60 percent of physicians say doctors have the most influence over device purchasing decisions currently, according to the "Deloitte 2013 Survey of U.S. Physicians: Physician perspectives about health care reform…
Last fall Kalamazoo, Mich.-based Stryker voluntarily urged physicians to discontinue use of its ShapeMatch orthopedic product, but recently the FDA upgraded the recall to a Class 1, indicating probability of serious health consequences or death, according to Michigan Live.
The Food and Drug Administration granted 31 orthopedic- and spine-related clearances in March.
Princeton, N.J.-based Regentis Biomaterials has increased the number of sites in its clinical trial of the GelrinC tissue regeneration implant.
The FDA has granted 510(k) clearance to EOS Imaging for its updated sterEOS 3-D imaging software.
Three health systems and a health benefits company have formed a joint venture to determine the quality of implantable medical devices.
Precision Spine appointed Tony Dimun as a member of the company's board of directors and as a special adviser for business development, mergers and acquisitions.
East Providence, RI-based IlluminOss Medical appointed Dirk Kuyper as president and chief executive officer.
